Herbert Kühl

No ORCID on file · 11 papers in corpus · active 1996-2011

Study types

  • article 8
  • review 3

Condition tags

  • dysmenorrhea 3
  • endometriosis 2
article 2011
Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy
·doi:10.1016/j.contraception.2011.01.002

BackgroundThe present study compared the efficacy and safety of a combined oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest (EE/DNG) in conventional and extended-cycle regimen over 1 year of treatment.Study designIn …

article 2010
Prescribing preferences and personal experience of female gynaecologists in Germany and Austria regarding use of extended-cycle oral contraceptives
·doi:10.3109/13625187.2010.518708

OBJECTIVES: To investigate prescribing preferences and personal experience of female gynaecologists with extended-cycle use of combined oral contraceptives (COCs) in Germany and Austria. METHODS: A questionnaire on prescribing patterns and …

article 2009
Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle use
·doi:10.1016/j.contraception.2009.07.011

BackgroundThe effects of extended regimens of combined oral contraceptives (COC) on lipid parameters are largely unknown. The present study compared the effects of a COC containing 30 mcg ethinyl estradiol and 2 mg dienogest (EE/DNG) in con…

review 2009
Langzyklus bei Ovulationshemmern
Therapeutische Umschau. Revue therapeutique ·doi:10.1024/0040-5930.66.2.101

Surveys show that most women desire a change in their menstrual pattern in the sense that they would prefer less menstruations or even amenorrhea. On this behalf, there is no difference between women having spontaneous natural cycles and wo…

article 2008
Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use
·doi:10.1016/j.contraception.2008.02.005

BackgroundThis study was conducted to investigate the effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters.Study designThyroid and androgen parameters were measu…

article 2008
Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters
·doi:10.1016/j.contraception.2008.06.015

BackgroundThe study was conducted to investigate the effect of a combined oral contraceptive (COC) containing 30 mcg ethinylestradiol and 2 mg dienogest with two different regimens on various hemostasis variables.Study designHemostatic para…

article 2006
Extended and Continuous Use of Hormonal Contraceptives to Reduce Menstruation
Women's health (London, England) ·doi:10.2217/17455057.2.5.705

During the use of long-cycle regimens of monophasic oral contraceptives, the total number of bleeding and cycle-dependent complaints is considerably lower than during conventional treatment with oral contraceptives. Despite an initially hig…

article 2006
Fertility after discontinuation of treatment with an oral contraceptive containing 30 μg of ethinyl estradiol and 2 mg of dienogest
·doi:10.1016/j.fertnstert.2005.11.052

ObjectiveTo examine the conception rate after cessation of a combination of 30 microg ethinyl E2 and 2 mg dienogest (EE/DNG).DesignProspective observational study.SettingPopulation-based cohort in Germany.Patient(s)Women who wished to becom…

review 2001
The new progestagens – advantages and disadvantages
·doi:10.1024/0040-5930.58.9.527

Due to their high oral bioavailability synthetic progestagens are used for therapy, hormone replacement therapy and contraception There are different types of progestogens. There are progesterone derivatives, nortestosterone derivatives (13…

article 1998
Dienogest
·doi:10.2165/00003495-199856050-00008
review 1996
Comparative Pharmacology of Newer Progestogens
·doi:10.2165/00003495-199651020-00002

The newer progestogens desogestrel, norgestimate, gestodene, dienogest and nomegestrol share the common property of having weak or no androgenic effects, but there is great variation between agents in their pharmacokinetic properties and ho…